Pyridoxal (Pyridoxine, Vitamin B6) Phosphatase (PDXP) (N-Term) Peptide
-
- Target See all PDXP products
- PDXP (Pyridoxal (Pyridoxine, Vitamin B6) Phosphatase (PDXP))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SNNSRRARPE LALRFARLGF GGLRAEQLFS SALCAARLLR QRLPGPPDAP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDXP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDXP (Pyridoxal (Pyridoxine, Vitamin B6) Phosphatase (PDXP))
- Synonyms
- CIN Peptide, PLP Peptide, dJ37E16.5 Peptide, 1600027H05Rik Peptide, AB041662 Peptide, PLPP Peptide, Rbp1 Peptide, pyridoxal phosphatase Peptide, pyridoxal (pyridoxine, vitamin B6) phosphatase Peptide, PDXP Peptide, Pdxp Peptide
- Background
-
Pyridoxal 5-prime-phosphate (PLP) is the active form of vitamin B6 that acts as a coenzyme in maintaining biochemical homeostasis. The preferred degradation route from PLP to 4-pyridoxic acid involves the dephosphorylation of PLP by PDXP.
Alias Symbols: CIN, PLP, dJ37E16.5
Protein Size: 296 - Molecular Weight
- 32 kDa
- Gene ID
- 57026
- NCBI Accession
- NM_020315, NP_064711
- UniProt
- Q96GD0
-